Choline Donor · Cognitive Performance

Citicoline (CDP-Choline): The Choline Form With the Most Human Attention and Memory Data

Unlike most nootropic choline sources, citicoline has been tested in two separate placebo-controlled human trials with statistically significant cognitive outcomes — one in attention, one in memory. Here's what the data actually shows.

p=0.04
Significance for reduced attention errors at 250mg/day (McGlade et al. 2012, N=60)
p=0.0025
Significance for improved episodic memory at 500mg/day (Nakazaki et al. 2021, N=100)
2 pathways
Delivers both choline (acetylcholine synthesis) and cytidine (membrane phospholipid synthesis)

What Is Citicoline and How Does It Work?

Citicoline — chemically cytidine 5'-diphosphocholine, abbreviated CDP-choline — is a naturally occurring intermediate in the biosynthesis pathway that builds phosphatidylcholine, the single most abundant phospholipid in neuronal cell membranes. It has been used clinically in Europe and Japan for decades (originally as a stroke and traumatic brain injury adjunct) before crossing over into the nootropic supplement market.

What makes citicoline mechanistically distinct from a simple choline source is that when it's absorbed and crosses into circulation, it splits into two separate bioactive components: choline and cytidine. Both cross the blood-brain barrier and are independently useful.

The Choline Pathway

The choline component feeds directly into acetylcholine synthesis — the neurotransmitter most associated with attention, learning, and memory encoding. This is the same general pathway targeted by other choline donors like Alpha-GPC, though the delivery kinetics differ.

The Cytidine/Uridine Pathway

Once past the blood-brain barrier, cytidine is converted to uridine, which combines with choline (recombined intracellularly into CDP-choline via the Kennedy pathway) to synthesize new phosphatidylcholine for membrane construction. This is the mechanism believed to underlie citicoline's use in neurological recovery contexts — it provides raw material for rebuilding and maintaining neuronal membrane integrity, not just neurotransmitter supply.

Mechanism summary: Citicoline is a dual-pathway compound — it supports acetylcholine-dependent attention and memory function (via the choline arm) while simultaneously supplying substrate for neuronal membrane phospholipid synthesis (via the cytidine/uridine arm). Few nootropics combine both mechanisms in a single molecule.

The Attention Trial: McGlade et al. 2012

McGlade, Locatelli, Hardy, et al. published "Improved Attentional Performance Following Citicoline Administration in Healthy Adult Women" in Food and Nutrition Sciences (2012, Vol. 3, No. 6). The study was a double-blind, randomized, placebo-controlled, three-arm design enrolling 60 healthy women aged 40-60, randomized to 250mg/day citicoline, 500mg/day citicoline, or placebo for 28 days.

Attention was measured using the Continuous Performance Test II (CPT-II), a standard computerized measure of sustained attention that tracks omission errors (missed targets) and commission errors (false-positive responses to non-targets). After 28 days, the 250mg citicoline group made significantly fewer omission errors (p=0.04) and commission errors (p=0.03) compared to the placebo group.

Notable detail: The lower 250mg dose outperformed the 500mg dose on statistical significance in this particular trial — a reminder that "more is better" doesn't reliably hold for choline donors, and dose-response isn't always linear.

The Memory Trial: Nakazaki et al. 2021

Nakazaki et al. published "Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" in The Journal of Nutrition (2021). This trial enrolled 100 healthy men and women aged 50-85 with age-associated memory impairment (AAMI), randomizing 49 to citicoline 500mg/day and 51 to placebo for 12 weeks; 99 of 100 participants completed the study.

Citicoline supplementation produced significantly greater improvement in episodic memory (mean improvement 0.15 vs. 0.06 for placebo, p=0.0025) and composite memory scores (mean 3.78 vs. 0.72, p=0.0052) compared to placebo.

Important context: Both trials were funded or supported by citicoline ingredient manufacturers (a common pattern across the nootropic supplement research base). The trial designs were nonetheless randomized and placebo-controlled, and the effect sizes and p-values reported are genuine — but independent, non-industry-funded replication in larger cohorts would strengthen confidence further.
Want the full evidence writeup?
The Stack Protocol builds four complete goal stacks — Energy, Focus, Sleep, Longevity — with exact doses, timing, budget tiers, and a 30-day rollout plan, graded with the same evidence framework behind this page.
Get the Stack Protocol → $19

Citicoline vs. Alpha-GPC

PropertyCiticoline (CDP-Choline)Alpha-GPC
Delivers cholineYesYes — higher elemental choline % by weight
Delivers cytidine/uridineYesNo
Human RCT attention/memory dataTwo placebo-controlled trials (McGlade 2012, Nakazaki 2021)More acute performance/growth-hormone research; less chronic cognitive-outcome data
Typical use caseChronic daily use for attention/memory supportAcute pre-workout cholinergic boost; power-output support
Typical dose250-500 mg/day300-600 mg/day

Dosing Protocols

Safety note: Citicoline has an extensive clinical safety record from decades of use as a stroke/TBI adjunct at doses well above nootropic supplement ranges. At 250-500 mg/day, reported side effects in trials were mild and comparable to placebo. Consult a physician before use if pregnant, nursing, or on prescription medication.
Citicoline (CDP-Choline) Supplement Look for a branded, standardized citicoline source (e.g. Cognizin) at 250mg or 500mg per serving
View on Amazon →
As an Amazon Associate, StackProtocol earns from qualifying purchases. Prices and availability may vary.

The StackProtocol Focus Stack

Citicoline Focus & Memory Stack

Citicoline's dual choline/cytidine mechanism pairs well with compounds that extend attention duration and buffer overstimulation

Citicoline — 250-500 mg (morning) Core choline donor and membrane-phospholipid substrate. Take consistently; cognitive trial outcomes were measured over 4-12 weeks, not acutely.
L-theanine + caffeine — 200mg / 100mg (as needed) Adds alpha-wave-associated calm focus and buffers overstimulation, complementing citicoline's slower-building attentional support.
Bacopa monnieri — 300 mg (daily, with food) Distinct memory-consolidation mechanism (non-cholinergic); commonly stacked with choline donors for a broader cognitive-support profile.
Citicoline + L-Theanine Focus Stack For sustained attention without overstimulation
View on Amazon →
As an Amazon Associate, StackProtocol earns from qualifying purchases.

Evidence Summary

Study / SourceFindingEvidence Level
McGlade et al. 2012
Food and Nutrition Sciences 3(6)		 N=60 healthy women 40-60; 250mg/day citicoline reduced omission (p=0.04) and commission (p=0.03) errors on CPT-II attention test vs. placebo over 28 days Human RCT (industry-supported)
Nakazaki et al. 2021
The Journal of Nutrition		 N=100 adults 50-85 with AAMI; 500mg/day citicoline improved episodic memory (p=0.0025) and composite memory (p=0.0052) vs. placebo over 12 weeks Human RCT (industry-supported)

Related Protocols

Alpha-GPC: Choline, Acetylcholine, and Growth HormoneCholine Donor · Cognitive · Performance
Bacopa Monnieri: Memory and FocusAdaptogen · Memory · Nootropic
L-Theanine + Caffeine: Cognitive Synergy for FocusNootropic Stack · Alpha Waves · Focus
A resource for your family
Scam calls targeting older adults are at record levels — the FBI logged $7.75 billion in reported losses from adults 60+ in 2025. Our free, no-signup guides show families exactly how the calls work — and the four rules that stop them.
Visit Scam-Proof Your Parents →
Weekly Research Digest
Get the free 30-Day Stack Log - plus the weekly digest

A one-variable-at-a-time fillable tracker for anything you add to your routine: log the dose, log a month of sleep and energy, and find out whether it did anything.

Free. Unsubscribe anytime. No spam, ever.

Frequently Asked Questions

What is citicoline and how is it different from choline?
Citicoline (cytidine 5'-diphosphocholine, or CDP-choline) is an intermediate compound in the biosynthesis of phosphatidylcholine, a major structural component of cell membranes. When ingested, it breaks down into choline and cytidine, both of which cross into the brain and are used to rebuild phospholipid membranes and support acetylcholine and uridine-related pathways.
What did the citicoline attention study find?
McGlade et al. (Food and Nutrition Sciences, 2012) gave 60 healthy women aged 40-60 either 250mg citicoline, 500mg citicoline, or placebo daily for 28 days. The 250mg group made significantly fewer omission errors (p=0.04) and commission errors (p=0.03) on the CPT-II attention test compared to placebo.
Does citicoline improve memory in older adults?
Nakazaki et al. (The Journal of Nutrition, 2021) randomized 100 adults aged 50-85 with age-associated memory impairment to 500mg/day citicoline or placebo for 12 weeks. The citicoline group showed significantly greater improvement in episodic memory (p=0.0025) and composite memory scores (p=0.0052) compared to placebo.
How does citicoline compare to Alpha-GPC?
Both are choline-donor nootropics, but citicoline additionally provides cytidine (which converts to uridine, supporting phospholipid synthesis and synaptic membrane formation), while Alpha-GPC is a more concentrated, faster-acting pure choline source often used pre-workout for its acute cholinergic effect. Citicoline has more placebo-controlled human cognitive-outcome data; Alpha-GPC has more acute performance/growth-hormone research.